AG2R La Mondiale Gestion d'Actifs’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.82M Buy
9,868
+341
+4% +$126K 0.14% 127
2026
Q1
$2.79M Buy
9,527
+126
+1% +$41.4K 0.13% 157
2025
Q4
$3.3M Buy
9,401
+668
+8% +$226K 0.15% 120
2025
Q3
$3.4M Hold
8,733
0.17% 112
2025
Q2
$3.4M Hold
8,733
0.17% 112
2025
Q1
$3.35M Buy
+8,733
New +$3.51M 0.18% 109

Other funds holding ELV

AG2R La Mondiale Gestion d'Actifs's ELV Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Elevance Health (ELV) stake by 3.6% in Q2 2026, buying an estimated $126K and bringing the position to 9,868 shares worth $3.82M. The position accounts for 0.14% of the portfolio, ranked #127.

AG2R La Mondiale Gestion d'Actifs first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 384 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 9,868 shares of Elevance Health worth $3.82M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs bought 341 Elevance Health shares in Q2 2026, an estimated $126K.
  • Elevance Health made up 0.14% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #127 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 384 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.